	Prognostic impact of primary Gleason pattern 5 in patients with low-volume metastatic hormone-sensitive prostate cancer treated with upfront ARPI-based doublet therapy: a real-world multicenter international collaborative study. Int J Clin Oncol Yamada Y, Sato K, Luo HL, Wang HJ, Liu HY, Chang YL, Su YL, Wu CT, Yu KJ, Lin PH, Liu CY, Ho DR, Huang YC, Tsujino T, Saito S, Maenosono R, Nishimura K, Fukushima T, Nakamura K, Yamamoto S, Arai T, Sato H, Higuchi K, Kurozumi A, Takei A, Kanesaka M, Ando K, Kurokawa K, Kanaoka S, Takeshita N, Yoneda K, Hino D, Tamura T, Sazuka T, Imamura Y, Mikami K, Nakamura K, Fukasawa S, Naya Y, Nagata M, Komaru A, Tobe T, Suzuki N, Azuma H, Sakamoto S. PMID: 42993239 [PubMed - as supplied by publisher]
	Comparison of PSMA- and CD70-targeted PET/CT in The Diagnosis of Renal Cell Carcinoma: A Retrospective Cohort and Prospective Head-to-head Study. Clin Cancer Res Li H, Liu Q, Yu X, Quan Z, Ye Y, Zhang M, Han T, Zhang M, Zhu Z, Yang W, Wang J, Yang X, Wei W, Kang F. PMID: 42993177 [PubMed - as supplied by publisher]
	Hypoxia Signatures in Renal Cell Carcinoma: From HIF-Mediated Omics Remodeling to Precision Diagnostics. J Proteome Res Mahalinga M, Rai AB, Prasad TSK. PMID: 42992921 [PubMed - indexed for MEDLINE]
	Testicular Cancer Survivorship: Navigating Long-Term Health Consequences. J Adv Pract Oncol Koehler AW. PMID: 42992181 [PubMed - as supplied by publisher]
	Neoadjuvant Nivolumab-Ipilimumab versus Platinum-Based Chemotherapy in Muscle-Invasive Bladder Cancer: A Single-Institution, Propensity-Weighted Cohort Study. Cancer Manag Res Huang LH, Tung MC, Weng WC, Hsu CY, Ou YC, Lin CC. PMID: 42992115 [PubMed]
	Quantitative assessment of perirenal fat density in renal cell carcinoma: a combined radiologist-driven and YOLO-based CT study. Front Radiol Sasani H, Özkan M, , Akgül HM, . PMID: 42991751 [PubMed]
	Spatial and single-cell insights into the prostate cancer microenvironment: overcoming immunotherapy resistance through multidimensional strategies. Front Immunol Liu D, Tang J, Jiang Y, Zhao J, Shen J, You L, Zheng Y. PMID: 42991555 [PubMed - indexed for MEDLINE]
	Therapy-induced methionine competition in bladder cancer: MAT2A-SAM axis remodeling as a metabolic immune checkpoint. Front Immunol Zhang C, Zhang Z, Bi J. PMID: 42991515 [PubMed - indexed for MEDLINE]
	Defining safe bladder preservation in BCG-unresponsive high-risk non-muscle-invasive bladder cancer: beyond complete response. Front Immunol Chen C, Xie B, Chen C, Gu P, Chen X. PMID: 42991509 [PubMed - indexed for MEDLINE]
	Five-fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single-institution retrospective cohort study. Oncol Lett Katano A, Yamashita H. PMID: 42991060 [PubMed]
	Mechanisms of resistance to immune checkpoint inhibitors in renal cell carcinoma and novel treatment strategies. Front Oncol Chen L, Cheng J, Mao S. PMID: 42991011 [PubMed]
	Prostate cancer screening beyond opportunistic testing: A Delphi consensus and evidence integration. Investig Clin Urol Ryu JH, Ko YH, Suh J, Han H, Bang W, Kim BH, Park SY, Chung JS, Joung JY, Byun SS, Park SW, Jeong BC, Joo KJ, Lee YG, Heo MH, Noh JW, Seo SI. PMID: 42990037 [PubMed - indexed for MEDLINE]
	Separation Science Perspectives on Processing-Induced Chemical Transformations of Natural Anti-Prostate Cancer Agents From Traditional Chinese Medicine. J Sep Sci Zhu J, Chen Z, Shen Y, Chang D. PMID: 42989872 [PubMed - indexed for MEDLINE]
	Magnetic Resonance Imaging Findings and Prostate-Specific Antigen Density-Based Risk Stratification for Deferring a Separate Preoperative Biopsy in Candidates for Holmium Laser Enucleation of the Prostate. Int J Urol Mitome T, Hirose H, Demizu N, Tokumoto M, Takebe S, Morikawa T, Morinaga R, Yoneyama S, Takizawa A. PMID: 42989579 [PubMed - indexed for MEDLINE]
	Mediterranean diet and risk of prostate cancer: a systematic review and meta-analysis of observational studies. BMC Nutr Jahnke TT, Holschuh C, Schlattmann P. PMID: 42989411 [PubMed]
	Prognostic role of preoperative low density to non-low-density lipoprotein cholesterol ratio in clear cell renal cell carcinoma: A retrospective study. Cancer Causes Control Qiao Y, Wang Z, Zheng H, Li Z, Dong Y, Tian G, Shen Y, Chong T, Chong Y. PMID: 42988996 [PubMed - indexed for MEDLINE]
	MYC in renal cell carcinoma pathogenic mechanisms and pharmacological intervention strategies. Biochem Pharmacol Mi H, Wei G, Zou L, Jin Q. PMID: 42988336 [PubMed - as supplied by publisher]
	Development and feasibility of a pharmacist delivered tobacco cessation intervention for prostate cancer patients and informal caregivers. J Am Pharm Assoc (2003) Dhumal T, Kamal KM, Scott VG, Hogan TF, Harper FWK, Kelly KM. PMID: 42988118 [PubMed - as supplied by publisher]
	Collagen Profiling by Second Harmonic Generation for Preliminary Discrimination Between Benign Prostatic Hyperplasia and Prostate Cancer. J Biophotonics Hu W, Zheng J, Xi G, Wang T, Wang H, Zhuo S, Xu H. PMID: 42987820 [PubMed - indexed for MEDLINE]
	Intravesical BCG-induced granulomatous prostatitis mimicking prostate cancer in patients with non-muscle invasive bladder cancer: a systematic review. World J Urol Miyajima K, Miszczyk M, Rabil MJ, Lübbersmeyer F, Tsuboi K, Matsukawa A, Urabe F, Mori K, Yanagisawa T, Leapman MS, Kimura T, Shariat SF. PMID: 42986441 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 182769

Page 1 of 9139



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy